» Articles » PMID: 27756825

The Association Between Dietary Vitamin A Intake and Pancreatic Cancer Risk: a Meta-analysis of 11 Studies

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2016 Oct 21
PMID 27756825
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Whether dietary vitamin A intake could reduce pancreatic cancer risk is still conflicting. We therefore conducted a meta-analysis to summarize the evidence from epidemiological studies. We searched the databases of PubMed and Web of Knowledge up to July 2016. Random model was used to combine study-specific relative risks (RR) and 95% confidence interval (CI). Publication bias was assessed by Egger regression asymmetry test and Begg's funnel plot. Eleven studies (10 case-control studies and 1 cohort study) involving 2705 pancreatic cancer cases were included in the present study. The RR (95% CI) of pancreatic cancer for highest category of vitamin A intake compared with lowest category was 0.839 (95% CI=0.712-0.988) with low heterogeneity detected (I=17.8%, P=0.274). The relationships were also significant for studies designed by case-control [RR=0.808, 95% CI=0.690-0.947], as well as in European population [RR=0.821, 95% CI=0.693-0.972]. No evidence of publication bias was found. This meta-analysis demonstrated that dietary vitamin A intake might inversely associated with the risk of pancreatic cancer.

Citing Articles

The therapeutic potential of vitamins A, C, and D in pancreatic cancer.

Piotrowsky A, Burkard M, Schmieder H, Venturelli S, Renner O, Marongiu L Heliyon. 2025; 11(1):e41598.

PMID: 39850424 PMC: 11754517. DOI: 10.1016/j.heliyon.2024.e41598.


Vitamin Nutritional Status in Patients with Pancreatic Cancer: A Narrative Review.

Azzini E, Furini T, Polito A, Scalfi L, Pinto A, Gasperi V Int J Mol Sci. 2024; 25(9).

PMID: 38732007 PMC: 11084158. DOI: 10.3390/ijms25094773.


Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer.

Montegut L, de Cabo R, Zitvogel L, Kroemer G Cancer Discov. 2022; 12(10):2258-2279.

PMID: 35997502 PMC: 10749912. DOI: 10.1158/2159-8290.CD-22-0504.


Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer.

Olakowski M, Buldak L Medicina (Kaunas). 2022; 58(8).

PMID: 35893093 PMC: 9394367. DOI: 10.3390/medicina58080978.


Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice.

Zhang Y, Zhang T, Yang W, Chen H, Geng X, Li G Front Oncol. 2021; 11:630972.

PMID: 34123787 PMC: 8193730. DOI: 10.3389/fonc.2021.630972.


References
1.
Bravi F, Polesel J, Bosetti C, Talamini R, Negri E, Dal Maso L . Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann Oncol. 2010; 22(1):202-206. DOI: 10.1093/annonc/mdq302. View

2.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

3.
Howe G, Jain M, Miller A . Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study. Int J Cancer. 1990; 45(4):604-8. DOI: 10.1002/ijc.2910450405. View

4.
Klapman J, Malafa M . Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control. 2008; 15(4):280-7. DOI: 10.1177/107327480801500402. View

5.
Higgins J, Thompson S . Controlling the risk of spurious findings from meta-regression. Stat Med. 2004; 23(11):1663-82. DOI: 10.1002/sim.1752. View